PMID- 20302777 OWN - NLM STAT- MEDLINE DCOM- 20160423 LR - 20181201 IS - 0253-2727 (Print) IS - 0253-2727 (Linking) VI - 31 IP - 1 DP - 2010 Jan TI - [Correlation of Bcl-2 with immunological subtype and prognosis in diffuse large B-cell lymphoma.]. PG - 34-7 AB - OBJECTIVE: To investigate the Bcl-2 protein and gene expression in diffuse large B-cell lymphoma (DLBCL), and analyze its correlation with immunosubtype and prognosis. METHODS: Seventy-three cases of DLBCL were performed immunohistochemistry analysis with a panel of antibodies CD3, CD10, CD20, Bcl-6, Bcl-2 and MUM-1, and classified into germinal center B-cell (GCB) type and non-GCB type. Fluorescence in situ hybridization (FISH) was employed to detect bcl-2 gene expression in 57 cases with chromosome translocation t (14;18). RESULTS: The percentages of tumor cells expressed CD10, Bcl-6, MUM-1 and Bcl-2 were 15.1%, 38.4%, 71.2% and 79.2%, respectively. 16 cases (21.9%) were GCB type and the rest (78.1%) were non-GCB type. 16 of 57 cases (28.1%) were t (14; 18), including 5 of GCB type (31.2%) and 11 of non-GCB type (68.2%). The expression of Bcl-2 protein was correlated with immunological subtype (P = 0.035), but not with survival time (P = 0.253). Between the t(14;18) positive and negtive groupes, there was significant difference for survival time (P = 0.022), but no difference for immunological subtype (P = 0.340). There was no correlation between Bcl-2 protein and t(14;18). CONCLUSIONS: GCB type DBLBCL with expression of Bcl-2 protein had a poor prognosis. t(14; 18) positive BLBCL had poor prognosis. The expression of Bcl-2 protein and t(14; 18) are usually discordant. FAU - Xi, Yan-Feng AU - Xi YF AD - Department of Pathology, Shanxi Tumor Hospital, Taiyuan 030013, China. FAU - Wang, Guo-Ping AU - Wang GP FAU - Li, Yi AU - Li Y FAU - Wang, Jin-Fen AU - Wang JF FAU - Sun, Rui-Fang AU - Sun RF LA - chi PT - Journal Article PL - China TA - Zhonghua Xue Ye Xue Za Zhi JT - Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi JID - 8212398 SB - IM MH - Genes, bcl-2 MH - Germinal Center MH - Humans MH - *In Situ Hybridization, Fluorescence MH - *Lymphoma, Large B-Cell, Diffuse MH - Prognosis EDAT- 2010/03/23 06:00 MHDA- 2016/04/24 06:00 CRDT- 2010/03/23 06:00 PHST- 2010/03/23 06:00 [entrez] PHST- 2010/03/23 06:00 [pubmed] PHST- 2016/04/24 06:00 [medline] PST - ppublish SO - Zhonghua Xue Ye Xue Za Zhi. 2010 Jan;31(1):34-7.